<VariationArchive VariationID="6607" VariationName="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs)" VariationType="Duplication" Accession="VCV000006607" Version="53" RecordType="classified" NumberOfSubmissions="15" NumberOfSubmitters="13" DateLastUpdated="2024-07-29" DateCreated="2014-11-09" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21646" VariationID="6607">
      <GeneList>
        <Gene Symbol="PNPLA6" FullName="patatin like phospholipase domain containing 6" GeneID="10908" HGNC_ID="HGNC:16268" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7534164" stop="7561767" display_start="7534164" display_stop="7561767" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7599037" stop="7626652" display_start="7599037" display_stop="7626652" Strand="+" />
          </Location>
          <OMIM>603197</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs)</Name>
      <CanonicalSPDI>NC_000019.10:7555724:GCCAGCC:GCCAGCCAGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7555724" stop="7555725" display_start="7555724" display_stop="7555725" variantLength="4" positionVCF="7555724" referenceAlleleVCF="C" alternateAlleleVCF="CGCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7620610" stop="7620611" display_start="7620610" display_stop="7620611" variantLength="4" positionVCF="7620610" referenceAlleleVCF="C" alternateAlleleVCF="CGCCA" />
      </Location>
      <ProteinChange>R1031fs</ProteinChange>
      <ProteinChange>R1021fs</ProteinChange>
      <ProteinChange>R956fs</ProteinChange>
      <ProteinChange>R983fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166113.1" sequenceAccession="NM_001166113" sequenceVersion="1" change="c.2944_2947dup">
            <Expression>NM_001166113.1:c.2944_2947dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159585.1" sequenceAccession="NP_001159585" sequenceVersion="1" change="p.Arg983fs">
            <Expression>NP_001159585.1:p.Arg983fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006702.4" sequenceAccession="NM_006702" sequenceVersion="4" change="c.2944_2947dup">
            <Expression>NM_006702.4:c.2944_2947dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.7555728_7555731dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.7555728_7555731dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.7620614_7620617dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.7620614_7620617dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013374.1" sequenceAccession="NG_013374" sequenceVersion="1" change="g.26577_26580dup">
            <Expression>NG_013374.1:g.26577_26580dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166111.2" sequenceAccession="NM_001166111" sequenceVersion="2" change="c.3088_3091dup">
            <Expression>NM_001166111.2:c.3088_3091dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159583.1" sequenceAccession="NP_001159583" sequenceVersion="1" change="p.Arg1031fs">
            <Expression>NP_001159583.1:p.Arg1031fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166112.2" sequenceAccession="NM_001166112" sequenceVersion="2" change="c.2863_2866dup">
            <Expression>NM_001166112.2:c.2863_2866dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159584.1" sequenceAccession="NP_001159584" sequenceVersion="1" change="p.Arg956fs">
            <Expression>NP_001159584.1:p.Arg956fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166114.2" sequenceAccession="NM_001166114" sequenceVersion="2" change="c.3058_3061dup" MANESelect="true">
            <Expression>NM_001166114.2:c.3058_3061dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159586.1" sequenceAccession="NP_001159586" sequenceVersion="1" change="p.Arg1021fs">
            <Expression>NP_001159586.1:p.Arg1021fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006702.5" sequenceAccession="NM_006702" sequenceVersion="5" change="c.2944_2947dup">
            <Expression>NM_006702.5:c.2944_2947dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006693.3" sequenceAccession="NP_006693" sequenceVersion="3" change="p.Arg983fs">
            <Expression>NP_006693.3:p.Arg983fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166111.1" sequenceAccession="NM_001166111" sequenceVersion="1" change="c.3088_3091dup">
            <Expression>NM_001166111.1:c.3088_3091dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006702.5" sequenceAccession="NM_006702" sequenceVersion="5" change="c.2944_2947dupAGCC">
            <Expression>NM_006702.5:c.2944_2947dupAGCC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA118372" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603197.0003" DB="OMIM" />
        <XRef Type="Allelic variant" ID="603197.0013" DB="OMIM" />
        <XRef Type="rs" ID="606231167" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 18313024 Fig. 4B to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Hereditary spastic paraplegia 39" Accession="RCV000006986" Version="17">
        <ClassifiedConditionList TraitSetID="1828">
          <ClassifiedCondition DB="MedGen" ID="C2677586">Hereditary spastic paraplegia 39</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-27" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Laurence-Moon syndrome" Accession="RCV000162351" Version="8">
        <ClassifiedConditionList TraitSetID="20952">
          <ClassifiedCondition DB="MedGen" ID="C0023138">Laurence-Moon syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Trichomegaly-retina pigmentary degeneration-dwarfism syndrome" Accession="RCV000162350" Version="8">
        <ClassifiedConditionList TraitSetID="20951">
          <ClassifiedCondition DB="MedGen" ID="C1848745">Trichomegaly-retina pigmentary degeneration-dwarfism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND not provided" Accession="RCV000627436" Version="24">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-11" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND PNPLA6-related disorder" Accession="RCV000779272" Version="6">
        <ClassifiedConditionList TraitSetID="47360">
          <ClassifiedCondition>PNPLA6-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-12" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Inborn genetic diseases" Accession="RCV001266496" Version="5">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Ataxia-hypogonadism-choroidal dystrophy syndrome" Accession="RCV001559126" Version="3">
        <ClassifiedConditionList TraitSetID="13240">
          <ClassifiedCondition DB="MedGen" ID="C1859093">Ataxia-hypogonadism-choroidal dystrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND Hereditary spastic paraplegia" Accession="RCV001847592" Version="4">
        <ClassifiedConditionList TraitSetID="8750">
          <ClassifiedCondition DB="MedGen" ID="C0037773">Hereditary spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166114.2(PNPLA6):c.3058_3061dup (p.Arg1021fs) AND multiple conditions" Accession="RCV002476938" Version="2">
        <ClassifiedConditionList TraitSetID="34001">
          <ClassifiedCondition DB="MedGen" ID="C1859093">Ataxia-hypogonadism-choroidal dystrophy syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2677586">Hereditary spastic paraplegia 39</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0023138">Laurence-Moon syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848745">Trichomegaly-retina pigmentary degeneration-dwarfism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-27" NumberOfSubmissions="15" NumberOfSubmitters="13" DateCreated="2014-11-09" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18313024</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23733235</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24355708</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25480986</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25574898</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31135245</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3963113</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8053762</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14327" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia</ElementValue>
                <XRef ID="Hereditary+spastic+paraplegia/3383" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019064" DB="MONDO" />
                <XRef ID="39912006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraparesis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500218" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592992" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508756" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6637" />
                <XRef ID="6637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301682</ID>
                <ID Source="BookShelf">NBK1509</ID>
              </Citation>
              <XRef ID="685" DB="Orphanet" />
              <XRef ID="C0037773" DB="MedGen" />
              <XRef ID="MONDO:0019064" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS303350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13240" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1438" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Boucher Neuhauser syndrome</ElementValue>
                <XRef ID="Boucher+Neuhauser+Syndrome/902" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chorioretinal dystrophy, spinocerebellar ataxia and hypogonadotropic hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia-hypogonadism-choroidal dystrophy syndrome</ElementValue>
                <XRef ID="MONDO:0008980" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BNHS</ElementValue>
                <XRef Type="MIM" ID="215470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="944" />
                <XRef ID="944" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PNPLA6-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="1180" DB="Orphanet" />
              <XRef ID="C1859093" DB="MedGen" />
              <XRef ID="MONDO:0008980" DB="MONDO" />
              <XRef Type="MIM" ID="215470" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47360" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41770" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PNPLA6-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PNPLA6-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">PNPLA6-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="34001" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3805" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NTE related motor neuron disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 39</ElementValue>
                <XRef ID="Spastic+paraplegia+39/6694" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 39</ElementValue>
                <XRef ID="MONDO:0012787" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPG39</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NTEMND</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4924" />
                <XRef ID="4924" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="139480" DB="Orphanet" />
              <XRef ID="C2677586" DB="MedGen" />
              <XRef ID="MONDO:0012787" DB="MONDO" />
              <XRef Type="MIM" ID="612020" DB="OMIM" />
            </Trait>
            <Trait ID="4293" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eyelashes, long with mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oliver-McFarlane syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Trichomegaly-retina pigmentary degeneration-dwarfism syndrome</ElementValue>
                <XRef ID="MONDO:0010152" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eyelashes long mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trichomegaly retina pigmentary degeneration dwarfism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trichomegaly with mental retardation, dwarfism and pigmentary degeneration of retina</ElementValue>
                <XRef ID="Trichomegaly+with+mental+retardation%2C+dwarfism+and+pigmentary+degeneration+of+retina/7200" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OMCS</ElementValue>
                <XRef Type="MIM" ID="275400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5266" />
                <XRef ID="5266" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="3363" DB="Orphanet" />
              <XRef ID="C1848745" DB="MedGen" />
              <XRef ID="MONDO:0010152" DB="MONDO" />
              <XRef Type="MIM" ID="275400" DB="OMIM" />
            </Trait>
            <Trait ID="2668" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Laurence-Moon syndrome</ElementValue>
                <XRef ID="MONDO:0009514" DB="MONDO" />
                <XRef ID="232059000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNMS</ElementValue>
                <XRef Type="MIM" ID="245800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12635" />
                <XRef ID="12635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="2377" DB="Orphanet" />
              <XRef ID="C0023138" DB="MedGen" />
              <XRef ID="MONDO:0009514" DB="MONDO" />
              <XRef Type="MIM" ID="245800" DB="OMIM" />
            </Trait>
            <Trait ID="1438" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Boucher Neuhauser syndrome</ElementValue>
                <XRef ID="Boucher+Neuhauser+Syndrome/902" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chorioretinal dystrophy, spinocerebellar ataxia and hypogonadotropic hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia-hypogonadism-choroidal dystrophy syndrome</ElementValue>
                <XRef ID="MONDO:0008980" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BNHS</ElementValue>
                <XRef Type="MIM" ID="215470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="944" />
                <XRef ID="944" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PNPLA6-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="1180" DB="Orphanet" />
              <XRef ID="C1859093" DB="MedGen" />
              <XRef ID="MONDO:0008980" DB="MONDO" />
              <XRef Type="MIM" ID="215470" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1828" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3805" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NTE related motor neuron disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603197.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 39</ElementValue>
                <XRef ID="Spastic+paraplegia+39/6694" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 39</ElementValue>
                <XRef ID="MONDO:0012787" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPG39</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NTEMND</ElementValue>
                <XRef Type="MIM" ID="612020" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4924" />
                <XRef ID="4924" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="139480" DB="Orphanet" />
              <XRef ID="C2677586" DB="MedGen" />
              <XRef ID="MONDO:0012787" DB="MONDO" />
              <XRef Type="MIM" ID="612020" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20951" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4293" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eyelashes, long with mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oliver-McFarlane syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Trichomegaly-retina pigmentary degeneration-dwarfism syndrome</ElementValue>
                <XRef ID="MONDO:0010152" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eyelashes long mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trichomegaly retina pigmentary degeneration dwarfism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trichomegaly with mental retardation, dwarfism and pigmentary degeneration of retina</ElementValue>
                <XRef ID="Trichomegaly+with+mental+retardation%2C+dwarfism+and+pigmentary+degeneration+of+retina/7200" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OMCS</ElementValue>
                <XRef Type="MIM" ID="275400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5266" />
                <XRef ID="5266" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="3363" DB="Orphanet" />
              <XRef ID="C1848745" DB="MedGen" />
              <XRef ID="MONDO:0010152" DB="MONDO" />
              <XRef Type="MIM" ID="275400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20952" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2668" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Laurence-Moon syndrome</ElementValue>
                <XRef ID="MONDO:0009514" DB="MONDO" />
                <XRef ID="232059000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNMS</ElementValue>
                <XRef Type="MIM" ID="245800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12635" />
                <XRef ID="12635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).</Attribute>
                <XRef ID="NBK247161" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299038</ID>
                <ID Source="BookShelf">NBK247161</ID>
              </Citation>
              <XRef ID="2377" DB="Orphanet" />
              <XRef ID="C0023138" DB="MedGen" />
              <XRef ID="MONDO:0009514" DB="MONDO" />
              <XRef Type="MIM" ID="245800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27182" SubmissionDate="2014-11-06" DateLastUpdated="2014-11-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603197.0003_SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE" title="PNPLA6, 4-BP INS, 2946CAGC_SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000027182" DateUpdated="2014-11-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The 2 affected individuals with motor neuron disease (SPG39; 612020) in the nonconsanguineous family described by Rainier et al. (2008) carried a 4-bp insertion on the maternal allele, 2946_2947insCAGC, that caused frameshift and protein truncation (Ser982fs1019). The paternal allele carried a missense mutation (603197.0002).</Attribute>
              <Citation>
                <ID Source="PubMed">18313024</ID>
              </Citation>
              <XRef DB="OMIM" ID="612020" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <Name>PNPLA6, 4-BP INS, 2946CAGC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 2946CAGC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603197.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790926" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="776491" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915849" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Comment>The PNPLA6 c.2944_2947dupAGCC (p.Arg983GlnfsTer38) variant results in a frameshift predicted to result in premature termination of the protein. The variant is also referred to in the literature as c.3084_3085insGCCA (p.Arg1031GlufsTer38). The p.Arg983GlnfsTer38 variant has been reported in at least three studies in which it is found in a compound heterozygous state with a missense variant in at least seven patients with a range of phenotypes, two of whom are siblings (Rainier et al. 2008; Synofzik et al. 2014; Hufnagel et al. 2015). The two siblings presented with progressive spastic paraplegia and distal muscle wasting (Rainer et al. 2008). The affected individuals reported by Synofzik et al. (2014) were diagnosed with sporadic ataxia and Gordon Holmes syndrome respectively while the three reported by Hufnagel et al. (2015) presented with Laurence-Moon syndrome. The variant is absent from 405 controls and is reported at a frequency of 0.000485 in the European American population of the Exome Sequencing Project. The p.Arg983GlnfsTer38 variant is predicted to result in the truncation of a large part of the catalytic domain of the protein (Rainier et al. 2008). Based on the potential impact of frameshift variants and the collective evidence, the p.Arg983GlnfsTer38 variant is classified as pathogenic for PNPLA6-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGCCA" referenceAllele="C" start="7620610" stop="7620610" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.4:c.2944_2947dupAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PNPLA6-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2866126" SubmissionDate="2020-11-14" DateLastUpdated="2021-05-16" DateCreated="2021-05-16">
        <ClinVarSubmissionID localKey="NM_001166111.1:c.3088_3091dup|OMIM:612020" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001451154" DateUpdated="2021-05-16" DateCreated="2021-05-16" Type="SCV" Version="1" SubmitterName="Paris Brain Institute, Inserm - ICM" OrgID="507826" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001166111.1:c.3088_3091dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612020" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8526155</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3495323" SubmissionDate="2021-08-11" DateLastUpdated="2022-10-01" DateCreated="2021-08-13">
        <ClinVarSubmissionID localKey="NM_006702.5:c.2944_2947dupAGCC|OMIM:215470" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001781211" DateUpdated="2022-10-01" DateCreated="2021-08-13" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25574898</ID>
          </Citation>
          <Comment>Reported across the PNPLA6 disorders phenotypic spectrum</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.5:c.2944_2947dupAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859093" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">25299038</ID>
          <ID Source="BookShelf">NBK247161</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB10187233</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="383652" SubmissionDate="2017-04-28" DateLastUpdated="2022-10-15" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="603197.0013_OLIVER-MCFARLANE SYNDROME" title="PNPLA6, 4-BP INS, 3091AGCC_OLIVER-MCFARLANE SYNDROME" />
        <ClinVarAccession Accession="SCV000212653" DateUpdated="2022-10-15" DateCreated="2015-03-24" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Oliver-McFarlane Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 2 unrelated families with a clinical diagnosis of Oliver-McFarlane syndrome (OMCS; 275400), one of which was originally reported by Patton et al. (1986), Hufnagel et al. (2015) identified compound heterozygous mutations in the PNPLA6 gene: a 4-bp insertion (c.3091_3092insAGCC) resulting in a frameshift and premature termination (Arg1031fs*38), on 1 allele, and a gly1129-to-arg missense mutation (G1129R; 603197.0014) on the other allele. The mutations were not found in over 300 ethnically matched controls or in the Exome Variant Server or 1000 Genomes Project databases.</Attribute>
              <Citation>
                <ID Source="PubMed">3963113</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25480986</ID>
              </Citation>
              <XRef DB="OMIM" ID="275400" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laurence-Moon Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with a clinical diagnosis of Laurence-Moon syndrome (LNMS; 245800), originally reported by Chalvon-Demersay et al. (1993), Hufnagel et al. (2015) identified compound heterozygous mutations in the PNPLA6 gene: the 4-bp insertion and a gly726-to-arg (G726R; 603197.0017) substitution. The mutations, which were found by exome sequencing, segregated with the disorder in the family. The G726R mutation was not found in over 300 ethnically matched controls or in the 1000 Genomes Project or Exome Variant Server databases.</Attribute>
              <Citation>
                <ID Source="PubMed">8053762</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25480986</ID>
              </Citation>
              <XRef DB="OMIM" ID="245800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <Name>PNPLA6, 4-BP INS, 3091AGCC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 3091AGCC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603197.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OLIVER-MCFARLANE SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="383653" SubmissionDate="2017-04-28" DateLastUpdated="2022-10-15" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="603197.0013_LAURENCE-MOON SYNDROME" title="PNPLA6, 4-BP INS, 3091AGCC_LAURENCE-MOON SYNDROME" />
        <ClinVarAccession Accession="SCV000212654" DateUpdated="2022-10-15" DateCreated="2015-03-24" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Oliver-McFarlane Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 2 unrelated families with a clinical diagnosis of Oliver-McFarlane syndrome (OMCS; 275400), one of which was originally reported by Patton et al. (1986), Hufnagel et al. (2015) identified compound heterozygous mutations in the PNPLA6 gene: a 4-bp insertion (c.3091_3092insAGCC) resulting in a frameshift and premature termination (Arg1031fs*38), on 1 allele, and a gly1129-to-arg missense mutation (G1129R; 603197.0014) on the other allele. The mutations were not found in over 300 ethnically matched controls or in the Exome Variant Server or 1000 Genomes Project databases.</Attribute>
              <Citation>
                <ID Source="PubMed">3963113</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25480986</ID>
              </Citation>
              <XRef DB="OMIM" ID="275400" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laurence-Moon Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with a clinical diagnosis of Laurence-Moon syndrome (LNMS; 245800), originally reported by Chalvon-Demersay et al. (1993), Hufnagel et al. (2015) identified compound heterozygous mutations in the PNPLA6 gene: the 4-bp insertion and a gly726-to-arg (G726R; 603197.0017) substitution. The mutations, which were found by exome sequencing, segregated with the disorder in the family. The G726R mutation was not found in over 300 ethnically matched controls or in the 1000 Genomes Project or Exome Variant Server databases.</Attribute>
              <Citation>
                <ID Source="PubMed">8053762</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25480986</ID>
              </Citation>
              <XRef DB="OMIM" ID="245800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <Name>PNPLA6, 4-BP INS, 3091AGCC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 3091AGCC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603197.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">LAURENCE-MOON SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5082018" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="NM_006702.4:c.2944_2947dupAGCC|PNPLA6-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002600471" DateUpdated="2022-11-19" DateCreated="2022-11-19" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20603202</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23733235</ID>
          </Citation>
          <Comment>Variant summary: PNPLA6 c.2944_2947dupAGCC (p.Arg983GlnfsX38), which has also been referred to in the literature as c.2946_2947insCAGC (p.S982fs1019), c.3084_3085insGCCA (p.Arg1031GlufsX38), and c.3091_3092insAGCC (p.Arg1031fsX38), results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00012 in 249798 control chromosomes, predominantly at a frequency of 0.00025 within the Non-Finnish European subpopulation in the gnomAD database. c.2944_2947dupAGCC has been reported in the literature in the compound heterozygous state in multiple individuals affected with PNPLA6-Related Disorders including spastic paraplegia, sporadic ataxia, Gordon Holmes syndrome, Oliver-McFarlane syndrome and Laurence-Moon syndrome (e.g. Rainier_2008, Synofzik_2014, Hufnagel_2015). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and found reduced enzyme activity (approximately 60% of normal) in fibroblasts from affected compound heterozygous individuals and also reduced activity (approximately 40% of normal) in unaffected carriers of the variant (Hein_2010). Eight submitters have provided assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.4:c.2944_2947dupAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PNPLA6-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5426750" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_006702.5:c.2944_2947dup|OMIM:215470;245800;275400;612020" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776097" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.5:c.2944_2947dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="215470" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="245800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="275400" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612020" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1063316" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="131597|MedGen:C2677586" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000550412" DateUpdated="2024-02-28" DateCreated="2015-10-11" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg983Glnfs*38) in the PNPLA6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PNPLA6 are known to be pathogenic (PMID: 24355708). This variant is present in population databases (rs764267161, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia, Gordon-Holmes syndrome, Boucher-Neuhauser syndrome, and Laurence-Moon syndrome (PMID: 18313024, 24355708, 25480986). ClinVar contains an entry for this variant (Variation ID: 6607). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.7620610_7620611insGCCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677586" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3682507" SubmissionDate="2021-09-13" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="NM_001166111.1:c.3088_3091dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001880151" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31135245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20603202</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25574898</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23733235</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. This variant is also referred to as c.2946_2947_insCAGC, c.3084_3085insGCCA, and c.3091_3092insAGCC in published literature.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001166111.1:c.3088_3091dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10229685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4119337" SubmissionDate="2022-03-15" DateLastUpdated="2022-03-19" DateCreated="2022-03-19">
        <ClinVarSubmissionID localKey="2022-00549|MONDO:0019064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002105476" DateUpdated="2022-03-19" DateCreated="2022-03-19" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.4:c.2944_2947dupAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019064" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11183483</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5409057" SubmissionDate="2022-12-20" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="330-20220820" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002764832" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001272" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0000135" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGCCA" referenceAllele="C" start="7620610" stop="7620610" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612020" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MRIHUMGEN_STATUS_20220809</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1457149" SubmissionDate="2022-10-19" DateLastUpdated="2023-03-04" DateCreated="2018-05-21">
        <ClinVarSubmissionID localKey="GDXSV:244079" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000748435" DateUpdated="2023-03-04" DateCreated="2018-05-21" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Has been reported previously (as c.2946_2947insCAGC or c.3084_3085insGCCA in some reports due to use of alternate nomenclature) in the compound heterozygous state with a second PNPLA6 variant in multiple individuals with spasticity and other PNPLA6-related symptoms (Ranier et al., 2008; Synofzik et al., 2014; O'Neil et al., 2019); Fibroblasts from two affected siblings demonstrated significantly reduced NTE special activity (Hein et al., 2010); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 35069422, 25480986, 25574898, 23733235, 24355708, 31135245, 33726816, 18313024, 27535533, 34531397, 34256108, 35947152, 3963113, 8053762, 20603202)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:748403</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.4:c.2944_2947dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_135_20221019054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_75_20211215054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2852762" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a978097|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001444671" DateUpdated="2024-05-01" DateCreated="2020-11-21" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18313024</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20603202</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23733235</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24355708</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25480986</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25574898</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31135245</ID>
          </Citation>
          <Comment>The c.2944_2947dupAGCC (p.R983Qfs*38) alteration, located in exon 27 (coding exon 25) of the PNPLA6 gene, consists of a duplication of AGCC at position 2944, causing a translational frameshift with a predicted alternate stop codon after 38 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been reported in multiple individuals with PNPLA6-related disorders and a second alteration in PNPLA6; however, the phase of the alterations was unclear (Rainier, 2008; Synofzik, 2013; Hufnagel, 2015; Kmoch, 2015; O'Neil, 2019). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006702.4:c.2944_2947dupAGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2471286" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-09">
        <ClinVarSubmissionID localKey="100957|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001249687" DateUpdated="2024-07-15" DateCreated="2020-05-09" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNPLA6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CGCCA" referenceAllele="C" start="7620610" stop="7620610" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1063316" TraitType="Disease" MappingType="XRef" MappingValue="C2677586" MappingRef="MedGen">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001272" MappingRef="HP">
        <MedGen CUI="C0740279" Name="Cerebellar atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2471286" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3495323" TraitType="Disease" MappingType="XRef" MappingValue="C1859093" MappingRef="MedGen">
        <MedGen CUI="C1859093" Name="Ataxia-hypogonadism-choroidal dystrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426750" TraitType="Disease" MappingType="XRef" MappingValue="215470" MappingRef="OMIM">
        <MedGen CUI="C1859093" Name="Ataxia-hypogonadism-choroidal dystrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="HP:0000135" MappingRef="HP">
        <MedGen CUI="C0020619" Name="Hypogonadism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001263" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426750" TraitType="Disease" MappingType="XRef" MappingValue="612020" MappingRef="OMIM">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="383652" TraitType="Disease" MappingType="Name" MappingValue="OLIVER-MCFARLANE SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1848745" Name="Trichomegaly-retina pigmentary degeneration-dwarfism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852762" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426750" TraitType="Disease" MappingType="XRef" MappingValue="245800" MappingRef="OMIM">
        <MedGen CUI="C0023138" Name="Laurence-Moon syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27182" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="612020" MappingRef="OMIM">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4119337" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019064" MappingRef="MONDO">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="383653" TraitType="Disease" MappingType="Name" MappingValue="LAURENCE-MOON SYNDROME" MappingRef="Alternate">
        <MedGen CUI="C0023138" Name="Laurence-Moon syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1457149" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426750" TraitType="Disease" MappingType="XRef" MappingValue="275400" MappingRef="OMIM">
        <MedGen CUI="C1848745" Name="Trichomegaly-retina pigmentary degeneration-dwarfism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790926" TraitType="Disease" MappingType="Name" MappingValue="PNPLA6-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="PNPLA6-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2866126" TraitType="Disease" MappingType="XRef" MappingValue="612020" MappingRef="OMIM">
        <MedGen CUI="C2677586" Name="Hereditary spastic paraplegia 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3682507" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5082018" TraitType="Disease" MappingType="Name" MappingValue="PNPLA6-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="PNPLA6-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409057" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528607</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

